Nautilus Biotechnology, Inc. (NAUT) vs Surrozen, Inc. (SRZN)
- Nautilus Biotechnology, Inc. NAUT 2.06 −4.63%
- Surrozen, Inc. SRZN 23.44 −6.50%
Nautilus Biotechnology, Inc. and Surrozen, Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and Surrozen, Inc. are of similar size ($294.7M and $274.9M). Nautilus Biotechnology, Inc. has the higher net margin (0.00% vs −2,887.1%) and the lower return on invested capital (−83.3% vs 0.00%). Across the 12 metrics below, Nautilus Biotechnology, Inc. leads on 7 and Surrozen, Inc. on 5.
Valuation
Profitability
| Metric | NAUT | SRZN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (385.28%) | 0.00% |
| Net margin | 0.00% | (2,887.07%) | 0.00% |
| Free cash flow margin | 0.00% | (303.92%) | 0.00% |
| Return on equity | (36.21%) | 387.44% | (56.36%) |
| Return on assets | (30.00%) | (304.47%) | (48.04%) |
| Return on invested capital | (83.32%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack